Right ventricular infarction complicates up to 50% of inferior MIs and typically results from proximal right coronary artery (RCA) occlusion. It defines a high-risk subgroup with increased morbidity and mortality compared to inferior MI without RV involvement (25–30% vs. 6% in-hospital mortality). [1-2] The hallmark management distinction is the critical need to maintain RV preload — making nitrates, diuretics, and other preload-reducing agents potentially dangerous. [1][3]
1. History
- Chest pain: substernal pressure/squeezing, radiation to jaw/arm/back; characterize onset, duration, severity, and response to rest or NTG
- Timing: sudden onset, relationship to exertion, symptom progression
- Associated symptoms: diaphoresis, nausea/vomiting (vagotonic symptoms are common with inferior/RV MI), dyspnea, lightheadedness, near-syncope or syncope [3]
- Ask about prior NTG use — patients with RVMI may have experienced profound hypotension after sublingual NTG [1][4]
- Important negatives: pleuritic quality, positional component, cough, leg swelling, recent immobilization (to differentiate from PE)
2. Alarm Features
- Hypotension (SBP <90 mmHg), especially after nitrate administration or volume depletion [1][3]
- Elevated JVP with clear lung fields — the classic triad of RVMI (hypotension + JVD + clear lungs) [5-6]
- Bradyarrhythmias: sinus bradycardia, high-degree AV block (common with inferior/RV MI due to RCA supply to the AV node) [3][7]
- Cardiogenic shock: cool extremities, altered mental status, oliguria
- New murmur (consider mechanical complications: VSD, papillary muscle rupture, tricuspid regurgitation) [5]
- Kussmaul sign (paradoxical rise in JVP with inspiration)
3. Medications
Contraindicated / Use with extreme caution
- Nitroglycerin (IV and sublingual) — reduces preload and can precipitate severe hypotension and cardiovascular collapse. ACC/AHA guidelines list nitrates as Class III (harm) in RV infarction. A recent meta-analysis suggests the absolute risk increase with sublingual NTG may be modest (~3 additional adverse events per 100 treatments), but current guidelines still recommend avoidance [3-4][8-10]
- Diuretics — reduce preload, worsen hemodynamics [1]
- Morphine — venodilator, use cautiously; can exacerbate hypotension
- Beta-blockers — avoid acutely, especially with bradycardia or hemodynamic instability [3]
- PDE5 inhibitors (sildenafil within 24h, tadalafil within 48h) — contraindicate nitrate use [8]
Indicated medications
- Aspirin and heparin (standard STEMI protocol) [3]
- Atropine for HR <50 bpm, even without frank hypotension [3]
- Dobutamine — first-line inotrope if volume loading fails to restore cardiac output [1][6]
- Milrinone — alternative inotrope, but watch for systemic vasodilation [6]
- Norepinephrine/vasopressin — for refractory hypotension to maintain coronary perfusion pressure
4. Diet
- NPO initially (anticipate catheterization lab)
- Avoid excessive oral fluid restriction; adequate hydration supports RV preload
- Post-acute phase: standard cardiac diet (low sodium, Mediterranean-style)
- Limit caffeine and alcohol during recovery
5. Review of Systems
- Cardiovascular: chest pain, palpitations, syncope/presyncope, orthopnea, PND, lower extremity edema
- Pulmonary: dyspnea (notably, lungs are typically clear in isolated RVMI — pulmonary edema suggests concomitant LV dysfunction) [5-6]
- GI: nausea, vomiting, epigastric pain (inferior MI can mimic GI pathology), RUQ pain (hepatic congestion from RV failure)
- Neurologic: lightheadedness, confusion (low output state)
- Genitourinary: decreased urine output (end-organ hypoperfusion)
6. Collateral History and Family History
- Collateral: time of symptom onset (critical for reperfusion window), medications taken (especially NTG, PDE5 inhibitors), prior cardiac history, functional baseline
- Family history: premature CAD (first-degree male relative <55, female <65), sudden cardiac death, familial hyperlipidemia
- Social: cocaine/stimulant use, smoking history, occupational stress
7. Risk Factors
- Standard CAD risk factors: hypertension, diabetes, dyslipidemia, smoking, obesity, family history of premature CAD
- Dominant RCA anatomy (most common) — proximal RCA occlusion is the typical culprit [2]
- Less commonly: left circumflex occlusion in left-dominant systems, or rarely LAD occlusion [2]
- Prior MI, known multivessel CAD (worsens prognosis: 1-year mortality 27% with combined right and left CAD vs. 18% with isolated RCA lesions) [2]
8. Differential Diagnosis
- Acute pulmonary embolism — RV dilation, hypotension, clear lungs; distinguished by ECG (S1Q3T3, sinus tachycardia vs. inferior ST elevation), CTPA, and McConnell sign on echo [3][6]
- Cardiac tamponade — JVD, hypotension, muffled heart sounds; distinguished by pulsus paradoxus, echo showing pericardial effusion with diastolic chamber collapse. Hemodynamics of RVMI more closely resemble constrictive pericarditis than tamponade [11]
- Constrictive pericarditis — similar hemodynamic profile (elevated and equalized filling pressures); distinguished by chronicity and imaging
- Tension pneumothorax — unilateral absent breath sounds, tracheal deviation
- Acute aortic dissection — tearing pain, pulse deficits, widened mediastinum; Type A can cause coronary malperfusion mimicking STEMI [5]
- LV-predominant cardiogenic shock — pulmonary edema present (unlike RVMI) [5]
- Takotsubo cardiomyopathy — apical ballooning, emotional trigger, typically anterior ST changes
9. Past Medical History
- Prior MI, PCI, or CABG
- Known coronary anatomy (prior catheterization)
- Heart failure, valvular disease
- Chronic kidney disease (contrast considerations for catheterization)
- Bleeding history (anticoagulation/antiplatelet decisions)
- Diabetes, hypertension, peripheral vascular disease
10. Physical Exam
Vital signs
- Hypotension (SBP <90 mmHg) — present in 25–50% with hemodynamically significant RVMI [2]
- Bradycardia — sinus bradycardia or AV block [3]
- Tachycardia may be absent (vagotonic physiology)
Key findings
- Elevated JVP / JVD — hallmark finding [5-6]
- Kussmaul sign — JVP rises with inspiration (highly specific)
- Clear lung fields on auscultation — distinguishes from LV failure [5-6]
- Right-sided S3 or S4 gallop
- Hepatomegaly and hepatojugular reflux (RV congestion)
- Cool, clammy extremities if in cardiogenic shock
- Pulsus paradoxus is typically absent (helps distinguish from tamponade) [11]
- Assess for new murmurs: holosystolic murmur at LLSB (VSD) or apex (MR)
11. Lab Studies
- Troponin (high-sensitivity): elevated; serial measurements to assess trend [12]
- BNP/NT-proBNP: may be elevated; helps assess degree of ventricular dysfunction
- BMP: electrolytes (K+, Mg2+ — arrhythmia risk), creatinine (contrast planning)
- CBC: baseline hemoglobin, platelets (bleeding risk with antithrombotics)
- Coagulation studies: PT/INR, aPTT (heparin dosing)
- Lactate: marker of tissue hypoperfusion in shock
- Liver function tests: may show congestive hepatopathy (elevated AST/ALT, bilirubin)
- Lipid panel, HbA1c: risk factor assessment (can be deferred)
- Type and screen: if considering mechanical support or surgery
12. Imaging
First-line
- Point-of-care echocardiography — definitive bedside assessment: RV dilation, RV free wall hypokinesis/akinesis, interventricular septal bowing toward LV, preserved vs. impaired LVEF, tricuspid regurgitation, IVC plethora [3][7]
- Chest X-ray: typically clear lung fields (no pulmonary edema in isolated RVMI); assess for cardiomegaly, widened mediastinum (aortic dissection)
Gold standard
- Coronary angiography — diagnostic and therapeutic (primary PCI); identifies culprit lesion (typically proximal RCA) [2][7]
- Cardiac MRI — best for quantifying RV infarct size, edema, and microvascular obstruction; typically performed post-acute phase [13]
When imaging is unnecessary
13. Special Tests
- Right-sided ECG leads (V3R, V4R) — the single most important diagnostic maneuver; ST elevation ≥0.5 mm in V4R (≥1 mm in men <30) is highly sensitive and specific for RVMI [3][7][12]
- Invasive hemodynamic monitoring (Swan-Ganz catheter): elevated RA pressure (≥10 mmHg), RA/PCWP ratio >0.8, depressed cardiac output; classic finding of elevated right-sided filling pressures disproportionate to left-sided pressures [1]
- TIMI risk score / GRACE score: standard ACS risk stratification
- Killip classification: assess heart failure severity
The following figure from Zehender et al. demonstrates the prognostic impact of ST-segment elevation in V4R on complications and mortality in inferior MI:
14. ECG
Key findings
- ST elevation in leads II, III, aVF (inferior STEMI) — present in virtually all cases of RVMI [1]
- ST elevation ≥0.5 mm in V4R — most sensitive and specific ECG marker; changes may be transient (obtain right-sided leads early) [3][12]
- ST elevation in V1 and aVR may also suggest RV involvement [12]
- Reciprocal ST depression in I, aVL
- AV conduction disturbances: first-degree AV block, Mobitz type I (Wenckebach), complete heart block [2-3]
- Sinus bradycardia (vagotonic response)
Dangerous patterns
- Complete heart block with hemodynamic compromise
- Ventricular tachycardia/fibrillation
- Absence of ST changes in right precordial leads does not exclude RVMI — changes may have resolved [12]
15. Assessment
Severity stratification
- Mild: RV wall motion abnormality on echo, hemodynamically stable, no arrhythmias
- Moderate: hypotension responsive to volume loading, transient bradyarrhythmias
- Severe: cardiogenic shock refractory to fluids, requiring inotropes/vasopressors or mechanical circulatory support [3]
RVMI represents a spectrum from asymptomatic RV dysfunction to frank cardiogenic shock. [1] Hemodynamic compromise occurs in 25–50% of patients. [2] The RV has remarkable resilience — most patients recover RV function within days to weeks after successful reperfusion, even after prolonged ischemia. [3] However, mortality is significantly higher when hemodynamic compromise is present, and the presence of concomitant LV dysfunction or multivessel disease worsens prognosis. [2]
Complications to consider
- High-degree AV block
- Ventricular arrhythmias (VT/VF)
- Atrial fibrillation (loss of atrial kick is poorly tolerated)
- Right-to-left shunting through patent foramen ovale (hypoxemia)
- Tricuspid regurgitation
- Mechanical complications (VSD, free wall rupture — rare)
16. Treatment Plan
Initial stabilization (ED)
- STOP nitrates and diuretics immediately if RVMI is suspected [1][3-4]
- Volume resuscitation: NS boluses (250–500 mL aliquots) targeting SBP >90 mmHg; reassess after each bolus with clinical exam and echo [1][6-7]
- Atropine 0.5–1 mg IV for symptomatic bradycardia (HR <50); transcutaneous pacing if refractory [3]
- Aspirin 325 mg + heparin (standard STEMI dosing) [3]
- P2Y12 inhibitor per institutional STEMI protocol
If volume loading fails (after 1–2 L)
- Dobutamine 2–20 mcg/kg/min — first-line inotrope [1][6]
- Norepinephrine for refractory hypotension to maintain coronary perfusion
- Avoid excessive volume — can worsen RV dilation and compromise LV filling via pericardial constraint and septal shift [1][6]
Definitive therapy
- Emergent reperfusion — primary PCI is the treatment of choice; successful reperfusion dramatically reduces arrhythmias, sustained hypotension, and in-hospital mortality [3][7]
- AV sequential pacing (not ventricular pacing alone) for complete heart block — atrial kick is critical [1]
- Prompt cardioversion for atrial fibrillation with hemodynamic compromise [1]
Escalation for refractory shock: [3]
- Mild hypotension: IABP may suffice
- Severe RV shock with preserved LV: percutaneous RVAD (e.g., Impella RP)
- Biventricular failure: pRVAD + LV Impella
- Profound collapse with poor oxygenation: VA-ECMO
17. Disposition
Admission criteria (all RVMI patients require admission)
- CCU/ICU: hemodynamic instability, cardiogenic shock, high-degree AV block, arrhythmias, need for inotropes/vasopressors or mechanical support [3]
- Telemetry/step-down: hemodynamically stable post-PCI, no arrhythmias, preserved LVEF
Specialist consultation triggers
- Interventional cardiology: immediate for all STEMI with RV involvement
- Cardiac surgery: mechanical complications, failed PCI, multivessel disease requiring CABG
- Advanced heart failure/MCS team: refractory cardiogenic shock [3]
Observation is not appropriate — all confirmed RVMI patients require inpatient management.
18. Follow Up / Return Precautions
In-hospital
- Hemodynamically stable, arrhythmia-free patients with intact LVEF can undergo rapid ambulation [3]
- Most patients recover RV function within days to weeks after successful reperfusion [2-3]
Post-discharge follow-up
- Cardiology follow-up within 1–2 weeks
- Repeat echocardiogram at 4–6 weeks to assess RV recovery
- Cardiac rehabilitation referral
- Optimize secondary prevention: DAPT, high-intensity statin, ACE inhibitor/ARB, beta-blocker (once hemodynamically stable), smoking cessation
Return precautions — instruct patients to seek immediate care for:
- Recurrent chest pain or pressure
- Lightheadedness, syncope, or near-syncope
- New or worsening shortness of breath
- Palpitations or sensation of irregular heartbeat
- Swelling in legs or abdomen
- Avoid NTG use unless specifically cleared by cardiologist
Expected recovery
- Late prognosis is excellent following successful reperfusion, with RV function typically returning to near-normal [1][3]
- Long-term mortality beyond the first year is approximately 2–3% per year through year 10 [2]
References
1. Right Ventricular Infarction. — Kinch JW, Ryan TJ. The New England Journal of Medicine. 1994.
2. Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association. — Konstam MA, Kiernan MS, Bernstein D, et al. Circulation. 2018.
3. Right Ventricular Myocardial Infarction-a Tale of Two Ventricles: JACC Focus Seminar 1/5. — Goldstein JA, Lerakis S, Moreno PR. Journal of the American College of Cardiology. 2024.
4. Treatment of Hypertension in Patients With Coronary Artery Disease: A Scientific Statement From the American Heart Association, American College of Cardiology, and American Society of Hypertension. — Rosendorff C, Lackland DT, Allison M, et al. Circulation. 2015.
5. Mechanical Complications of Acute Myocardial Infarction: A Scientific Statement From the American Heart Association. — Damluji AA, van Diepen S, Katz JN, et al. Circulation. 2021.
6. Right Ventricular Failure. — Houston BA, Brittain EL, Tedford RJ. The New England Journal of Medicine. 2023.
7. ACC/AHA Guidelines for the Management of Patients With ST-elevation Myocardial Infarction--Executive Summary. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). — Antman EM, Anbe DT, Armstrong PW, et al. Journal of the American College of Cardiology. 2004.
8. ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-St-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-St-Elevation Myocardial Infarction) Developed in Collaboration With the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. — Anderson JL, Adams CD, Antman EM, et al. Journal of the American College of Cardiology. 2007.
9. 2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-St-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the American Academy of Family Physicians, Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons. — Wright RS, Anderson JL, Adams CD, et al. Journal of the American College of Cardiology. 2011.
10. Adverse Events From Nitrate Administration During Right Ventricular Myocardial Infarction: A Systematic Review and Meta-Analysis. — Wilkinson-Stokes M, Betson J, Sawyer S. Emergency Medicine Journal : EMJ. 2023.
11. Right Ventricular Infarction. Clinical Diagnosis and Differentiation From Cardiac Tamponade and Pericardial Constriction. — Lorell B, Leinbach RC, Pohost GM, et al. The American Journal of Cardiology. 1979.
12. Fourth Universal Definition of Myocardial Infarction (2018). — Thygesen K, Alpert JS, Jaffe AS, et al. Journal of the American College of Cardiology. 2018.
13. Frequency and Prognostic Impact of Right Ventricular Involvement in Acute Myocardial Infarction. — Stiermaier T, Backhaus SJ, Matz J, et al. Heart. 2020.
14. Right Ventricular Infarction as an Independent Predictor of Prognosis after Acute Inferior Myocardial Infarction. — Zehender M, Kasper W, Kauder E, et al. The New England Journal of Medicine. 1993.